ArticleJournal of general internal medicine2021

Rates of Metformin Use in Stage 3b Chronic Kidney Disease Rose After FDA Label Change.

Alex Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.